Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | nuclear receptor NHR-88 | 0.0021 | 0.0013 | 0.0018 |
Schistosoma mansoni | Tr4/Tr2 (homologue) | 0.0021 | 0.0013 | 0.0125 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.0021 | 0.0013 | 0.0018 |
Echinococcus multilocularis | ecdysone induced protein 78C | 0.0021 | 0.0013 | 0.0046 |
Schistosoma mansoni | thyroid hormone receptor | 0.015 | 0.1061 | 1 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0021 | 0.0013 | 0.0046 |
Echinococcus multilocularis | FTZ F1 alpha | 0.0021 | 0.0013 | 0.0046 |
Echinococcus granulosus | COUP TF:Svp nuclear hormone receptor | 0.0021 | 0.0013 | 0.0046 |
Schistosoma mansoni | nuclear hormone receptor | 0.0021 | 0.0013 | 0.0125 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0013 | 0.0069 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0021 | 0.0013 | 0.0018 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.015 | 0.1061 | 0.3708 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0013 | 0.0069 |
Echinococcus granulosus | Nuclear hormone receptor family member nhr 41 | 0.0021 | 0.0013 | 0.0046 |
Entamoeba histolytica | proliferating cell nuclear antigen, putative | 0.0031 | 0.0099 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.0021 | 0.0013 | 0.0069 |
Echinococcus granulosus | hepatocyte nuclear factor 4 alpha | 0.0021 | 0.0013 | 0.0046 |
Schistosoma mansoni | steroid hormone receptor ad4bp | 0.0021 | 0.0013 | 0.0125 |
Echinococcus granulosus | proliferating cell nuclear antigen | 0.0031 | 0.0099 | 0.0345 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.0021 | 0.0013 | 0.0069 |
Plasmodium falciparum | telomerase reverse transcriptase | 0.0343 | 0.2619 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0021 | 0.0013 | 0.0069 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.0021 | 0.0013 | 0.0018 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0256 | 0.1918 | 0.2655 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0021 | 0.0013 | 0.0018 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0026 | 0.0059 | 0.0206 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.013 | 0.0893 | 0.312 |
Echinococcus multilocularis | Nuclear hormone receptor family member nhr 41 | 0.0021 | 0.0013 | 0.0046 |
Brugia malayi | Telomerase reverse transcriptase | 0.0913 | 0.7226 | 1 |
Echinococcus granulosus | FTZ F1 alpha | 0.0021 | 0.0013 | 0.0046 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0021 | 0.0013 | 0.0018 |
Schistosoma mansoni | proliferating cell nuclear antigen | 0.0031 | 0.0099 | 0.0932 |
Giardia lamblia | Telomerase catalytic subunit | 0.0343 | 0.2619 | 1 |
Echinococcus granulosus | expressed protein | 0.0373 | 0.2862 | 1 |
Plasmodium vivax | telomerase reverse transcriptase, putative | 0.0343 | 0.2619 | 1 |
Leishmania major | telomerase reverse transcriptase, putative | 0.0343 | 0.2619 | 1 |
Echinococcus multilocularis | expressed protein | 0.0373 | 0.2862 | 1 |
Toxoplasma gondii | RNA-directed DNA polymerase | 0.0343 | 0.2619 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0013 | 0.0069 |
Schistosoma mansoni | retinoid-x-receptor (RXR) | 0.0021 | 0.0013 | 0.0125 |
Trichomonas vaginalis | proliferating cell nuclear antigen, putative | 0.0031 | 0.0099 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0013 | 0.0069 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0013 | 0.0069 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0343 | 0.2619 | 1 |
Schistosoma mansoni | hypothetical protein | 0.013 | 0.0893 | 0.8415 |
Trypanosoma cruzi | telomerase reverse transcriptase, putative | 0.0343 | 0.2619 | 1 |
Schistosoma mansoni | coup transcription factor | 0.0021 | 0.0013 | 0.0125 |
Echinococcus multilocularis | proliferating cell nuclear antigen | 0.0031 | 0.0099 | 0.0345 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0021 | 0.0013 | 0.0046 |
Schistosoma mansoni | thyroid hormone receptor | 0.015 | 0.1061 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.0021 | 0.0013 | 0.0069 |
Echinococcus multilocularis | hepatocyte nuclear factor 4 alpha | 0.0021 | 0.0013 | 0.0046 |
Loa Loa (eye worm) | hypothetical protein | 0.0255 | 0.1909 | 0.995 |
Schistosoma mansoni | proliferating cell nuclear antigen | 0.0031 | 0.0099 | 0.0932 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.0021 | 0.0013 | 0.0018 |
Schistosoma mansoni | nuclear hormone receptor nor-1/nor-2 | 0.0021 | 0.0013 | 0.0125 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0013 | 0.0069 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.0021 | 0.0013 | 0.0069 |
Schistosoma mansoni | photoreceptor-specific nuclear receptor related | 0.0021 | 0.0013 | 0.0125 |
Loa Loa (eye worm) | nuclear hormone receptor-like 1 | 0.0256 | 0.1918 | 1 |
Echinococcus multilocularis | nuclear receptor 2DBD gamma | 0.0021 | 0.0013 | 0.0046 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0026 | 0.0059 | 0.0206 |
Trypanosoma brucei | telomerase reverse transcriptase | 0.0343 | 0.2619 | 1 |
Brugia malayi | proliferating cell nuclear antigen (PCNA) | 0.0031 | 0.0099 | 0.0137 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.0021 | 0.0013 | 0.0018 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.0021 | 0.0013 | 0.0018 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0021 | 0.0013 | 0.0046 |
Echinococcus granulosus | FTZ F1 nuclear receptor protein | 0.0021 | 0.0013 | 0.0046 |
Echinococcus granulosus | nuclear receptor 2DBD gamma | 0.0021 | 0.0013 | 0.0046 |
Schistosoma mansoni | RAR-like nuclear receptor | 0.0021 | 0.0013 | 0.0125 |
Echinococcus multilocularis | FTZ F1 nuclear receptor protein | 0.0021 | 0.0013 | 0.0046 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.0021 | 0.0013 | 0.0069 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0021 | 0.0013 | 0.0069 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0021 | 0.0013 | 0.0018 |
Loa Loa (eye worm) | proliferating cell nuclear antigen | 0.0031 | 0.0099 | 0.0515 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0013 | 0.0069 |
Trichomonas vaginalis | proliferating cell nuclear antigen, putative | 0.0031 | 0.0099 | 1 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0021 | 0.0013 | 0.0018 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0026 | 0.0059 | 0.0206 |
Schistosoma mansoni | nuclear receptor 2DBD-gamma | 0.0021 | 0.0013 | 0.0125 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0266 | 0.1998 | 0.2765 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.0021 | 0.0013 | 0.0018 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.013 | 0.0893 | 0.312 |
Echinococcus granulosus | ecdysone induced protein 78C | 0.0021 | 0.0013 | 0.0046 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0021 | 0.0013 | 0.0018 |
Brugia malayi | steroid hormone receptor | 0.0021 | 0.0013 | 0.0018 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0021 | 0.0013 | 0.0018 |
Brugia malayi | ecdysteroid receptor | 0.0021 | 0.0013 | 0.0018 |
Brugia malayi | nuclear hormone receptor | 0.0021 | 0.0013 | 0.0018 |
Schistosoma mansoni | FTZ-F1 nuclear receptor-like protein | 0.0021 | 0.0013 | 0.0125 |
Echinococcus multilocularis | COUP TF:Svp nuclear hormone receptor | 0.0021 | 0.0013 | 0.0046 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0256 | 0.1918 | 0.2655 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.0021 | 0.0013 | 0.0069 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0013 | 0.0069 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0021 | 0.0013 | 0.0125 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.0021 | 0.0013 | 0.0018 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.0021 | 0.0013 | 0.0018 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Kd (ADMET) | = 40 uM | Apparent dissociation (binding) rate constant of the compound was evaluated | ChEMBL. | 3965709 |
Ki (ADMET) | = 0.09 min-1 | Apparent inactivation rate constant of the compound was evaluated | ChEMBL. | 3965709 |
Log rate (ADMET) | = 1.4 | Observed log rate of methylthio adduct formation | ChEMBL. | 4045921 |
Protection (functional) | = 2.9 % | Percent protection from inactivation of AHAT was determined using t-RNA | ChEMBL. | 3965709 |
Protection (functional) | = 5.9 % | Percent protection from inactivation of AHAT was determined using guanosine phosphate | ChEMBL. | 3965709 |
Protection (functional) | = 8 % | Percent protection from inactivation of AHAT was determined using L-methionine | ChEMBL. | 3965709 |
Protection (functional) | = 30.5 % | Percent protection from inactivation of AHAT was determined using glutathione | ChEMBL. | 3965709 |
Protection (functional) | = 35.9 % | Percent protection from inactivation of AHAT was determined using L-cysteine | ChEMBL. | 3965709 |
Rate (ADMET) | = 16.5 nM | Activity measured as 4-aminoazobenzene (AAB) transacetylation rate with partially purified hamster hepatic enzyme | ChEMBL. | 3965709 |
Rate (ADMET) | = 24.9 nM | Rate of methylthio adduct formation catalyzed by partially purified hamster hepatic enzyme per mg protein per 10 min | ChEMBL. | 4045921 |
Ratio (ADMET) | = 37.5 M-1 s-1 | Ratio of apparent inactivation rate constant to apparent dissociation (binding) rate constant was determined | ChEMBL. | 3965709 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.